Anti-Inflammatory Therapy With Canakinumab for the Prevention of Hospitalization for Heart Failure
Sign Up to like & getrecommendations! Published in 2019 at "Circulation"
DOI: 10.1161/circulationaha.118.038010
Abstract: Background: Subclinical inflammation is associated with an increased risk of heart failure and with adverse prognosis in patients with established heart failure. Yet, treatments specifically directed at reducing inflammation in patients with heart failure have… read more here.
Keywords: hospitalization heart; canakinumab; composite hhf; heart ... See more keywords